|
SE0100172D0
(sv)
|
2001-01-22 |
2001-01-22 |
Ulf Nilsson |
New inhibitors against galectins
|
|
SE0401300D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel Galactoside Inhibitors of Galectins
|
|
SE0401301D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel 3-triazolyl-galactoside inhibitors of galectins
|
|
DK2906227T3
(en)
|
2012-10-10 |
2018-12-10 |
Galectin Therapeutics Inc |
GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy
|
|
CN104755088A
(zh)
|
2012-10-31 |
2015-07-01 |
格莱克特生物技术公司 |
半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用
|
|
EP2919802A4
(en)
|
2012-11-15 |
2016-09-14 |
Univ Tufts |
METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
|
|
CA2970062C
(en)
|
2015-01-30 |
2023-02-28 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
PL3456717T3
(pl)
|
2015-07-06 |
2021-10-25 |
Gilead Sciences, Inc. |
Pochodna 4,6-diaminochinolino-3-karbonitrylu jako modulator cot (cancer osaka thyroid) do leczenia choroby zapalnej
|
|
CA3025867A1
(en)
|
2016-07-12 |
2018-01-18 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
KR20200015528A
(ko)
|
2017-05-12 |
2020-02-12 |
갈랙틴 사이언시즈, 엘엘씨 |
전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
|
|
EP3621973A4
(en)
|
2017-05-12 |
2021-10-27 |
Galectin Sciences, LLC |
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF
|
|
WO2019067702A1
(en)
*
|
2017-09-27 |
2019-04-04 |
Bristol-Myers Squibb Company |
INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
|
|
US11072626B2
(en)
|
2017-10-11 |
2021-07-27 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of Galectin-3
|
|
CA3080128A1
(en)
|
2017-10-31 |
2019-05-09 |
Galectin Sciences, Llc |
Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
CN113286632A
(zh)
|
2018-10-15 |
2021-08-20 |
格莱克特生物技术公司 |
半乳糖凝集素的半乳糖苷抑制剂前药
|
|
JP2022508720A
(ja)
|
2018-10-15 |
2022-01-19 |
ガレクト バイオテック エービー |
ガレクチンのガラクトシド阻害剤
|
|
WO2020104335A1
(en)
|
2018-11-21 |
2020-05-28 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
CA3122321A1
(en)
*
|
2018-12-27 |
2020-07-02 |
Glycomimetics, Inc. |
Galectin-3 inhibiting c-glycosides
|
|
EP3947407B1
(en)
*
|
2019-03-26 |
2024-06-12 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of galectin-3
|
|
US12269819B2
(en)
*
|
2019-04-10 |
2025-04-08 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of Galectin-3
|
|
JP7674276B2
(ja)
|
2019-07-03 |
2025-05-09 |
ガレクト バイオテック エービー |
ガレクチンの新規なガラクトシド阻害剤
|
|
WO2021004940A1
(en)
|
2019-07-05 |
2021-01-14 |
Galecto Biotech Ab |
Novel galactoside inhibitor of galectins
|
|
WO2021028323A1
(en)
|
2019-08-09 |
2021-02-18 |
Idorsia Pharmaceuticals Ltd |
(2-acetamidyl)thio-beta-d-galactopyranoside derivatives
|
|
CN114206893A
(zh)
|
2019-08-09 |
2022-03-18 |
爱杜西亚药品有限公司 |
(杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
|
|
MA56883B1
(fr)
|
2019-08-15 |
2025-04-30 |
Idorsia Pharmaceuticals Ltd |
Dérivés de 2-hydroxycycloalcane-1-carbamoyle
|
|
CN114585619B
(zh)
|
2019-08-29 |
2024-09-27 |
爱杜西亚药品有限公司 |
α-D-吡喃半乳糖苷衍生物
|
|
US12312362B2
(en)
|
2020-10-06 |
2025-05-27 |
Idorsia Pharmaceuticals Ltd |
Spiro derivatives of Alpha-D-galactopyranosides
|
|
CN116806219A
(zh)
|
2021-02-09 |
2023-09-26 |
爱杜西亚药品有限公司 |
羟基杂环烷-氨甲酰基衍生物
|
|
RS67032B1
(sr)
|
2021-03-03 |
2025-08-29 |
Idorsia Pharmaceuticals Ltd |
Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom
|